Raymond Prudo-Chlebosz

Raymond Prudo-Chlebosz

Gründer bei AKARI THERAPEUTICS, PLC

Vermögen: 6 Mio $ am 31.07.2023

79 Jahre
Health Technology
Health Services
Consumer Services

Ursprung des Netzwerks ersten Grades von Raymond Prudo-Chlebosz

EinheitArt der EinheitIndustrie
Public Company Biotechnology 26
9
Private Company Medical/Nursing Services 9
6
Subsidiary Medical/Nursing Services 6
3
Subsidiary Pharmaceuticals: Major 3
Varleigh Immuno Pharmaceuticals Uk Ltd.
1
Private Company 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Raymond Prudo-Chlebosz

UnternehmenSektorVerknüpfte PersonenHauptposition
KERYX BIOPHARMACEUTICALS Pharmaceuticals: Major

Melissa Bradford-Klug

John Neylan

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Medical Specialties

John Neylan

Corporate Officer/Principal

College/University

John Neylan

Undergraduate Degree

SONIC HEALTHCARE LIMITED Medical/Nursing Services

Colin Goldschmidt

Christopher Wilks

Chief Executive Officer

Director of Finance/CFO

SILENCE THERAPEUTICS PLC Miscellaneous Commercial Services

David Solomon

Chief Executive Officer

Miscellaneous Commercial Services

Colin Goldschmidt

Christopher Wilks

Director/Board Member

Director/Board Member

SILEX SYSTEMS LIMITED Semiconductors

Colin Goldschmidt

Christopher Wilks

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Allan Shaw

Wendy DiCicco

Jacques Suzanne

Corporate Officer/Principal

Comptroller/Controller/Auditor

Comptroller/Controller/Auditor

Miscellaneous Commercial Services

Allan Shaw

Wendy DiCicco

Corporate Officer/Principal

Corporate Officer/Principal

Emory University College/University

John Neylan

Corporate Officer/Principal

VALERIO THERAPEUTICS Pharmaceuticals: Major

David Solomon

Director/Board Member

DePaul University College/University

Melissa Bradford-Klug

Masters Business Admin

Rutgers State University of New Jersey College/University

Mark S. Cohen

Undergraduate Degree

Maryville University of St. Louis College/University

Melissa Bradford-Klug

Undergraduate Degree

New York University College/University

Mark S. Cohen

Graduate Degree

Miscellaneous Commercial Services

Melissa Bradford-Klug

Director/Board Member

Miscellaneous Commercial Services

John Neylan

Corporate Officer/Principal

AMAG PHARMACEUTICALS, INC. Pharmaceuticals: Major

Melissa Bradford-Klug

Corporate Officer/Principal

TXCELL Miscellaneous Commercial Services

David Solomon

Director/Board Member

Packaged Software

Clive Richardson

David Byrne

Director/Board Member

Director/Board Member

Weill Cornell Medical College College/University

David Solomon

Doctorate Degree

Medical/Nursing Services

Colin Goldschmidt

Christopher Wilks

Director/Board Member

Director/Board Member

Financial Conglomerates

Colin Goldschmidt

Christopher Wilks

David Byrne

Director/Board Member

Director/Board Member

Chief Executive Officer

ADVICENNE Pharmaceuticals: Generic

David Solomon

Chairman

Miscellaneous Commercial Services

David Solomon

Director/Board Member

ImpediMed, Inc.

Donald Williams

Director/Board Member

Rush Medical College College/University

John Neylan

Doctorate Degree

University of Baltimore School of Law College/University

Mark S. Cohen

Graduate Degree

Medical Specialties

Colin Goldschmidt

Christopher Wilks

Director/Board Member

Director/Board Member

The Cass Foundation

David Solomon

Director/Board Member

Medical/Nursing Services

Colin Goldschmidt

Christopher Wilks

David Byrne

Lisa Levett

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Melissa Bradford-Klug

Corporate Officer/Principal

Packaged Software

Clive Richardson

David Byrne

Director/Board Member

Director of Finance/CFO

WestPac Labs, Inc.

Colin Goldschmidt

Christopher Wilks

Director/Board Member

Director/Board Member

Medical/Nursing Services

Colin Goldschmidt

Christopher Wilks

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Mark S. Cohen

Chairman

Medical Specialties

Mark S. Cohen

Director/Board Member

Pharmaceuticals: Major

Melissa Bradford-Klug

Chief Executive Officer

Biotechnology

Melissa Bradford-Klug

President

Miscellaneous Commercial Services

Donald Williams

Director/Board Member

Financial Conglomerates

David Solomon

Chief Executive Officer

Biotechnology

David Solomon

Chief Executive Officer

Statistik

International

Vereinigte Staaten 28
Vereinigtes Königreich 11
Australien 4
Frankreich 4
Dänemark 3

Sektoral

Health Technology 18
Commercial Services 11
Consumer Services 10
Health Services 5
Technology Services 3

Operativ

Director/Board Member 132
Corporate Officer/Principal 50
Independent Dir/Board Member 38
Chief Executive Officer 31
Director of Finance/CFO 30
  1. Börse
  2. Insiders
  3. Raymond Prudo-Chlebosz
  4. Unternehmensverbindungen